Navigation Links
Anti-Craving Drug, Naltrexone Helps Women Quit Smoking

A new study finds that the anti-craving drug, Naltrexone may lessen cessation-related weight gain and negative moods and women who are trying to quit smoking appear //to benefit more than men. As a first step towards individualized medicine, scientists are focusing on gender differences in nicotine addiction and in treatment.

Researchers Andrea King and her colleagues of the University of Chicago have added a drug called Naltrexone to traditional methods of quitting smoking like the nicotine patch and counseling. Naltrexone is believed to block the chemical signals that relay pleasure to the brain. The study randomly assigned 110 adult smokers to receive two months of Naltrexone (brand name Revia) or inactive placebo pills in combination with six months of behavioral counseling sessions and one month of the nicotine patch.

But Naltrexone seemed to help the women more than the men. 58% of female smokers taking the drug were able to quit, compared with only 39% of those taking placebos. In contrast, the quit rates in men taking Naltrexone or placebo were almost the same.

"Women seem to be more sensitive to Naltrexone in terms of its decrease in their negative mood symptoms during withdrawal," King says. "Naltrexone also significantly decreased their craving. With men, there was no difference. The nicotine patch for men seems to do the trick." Naltrexone also prevented the weight gain that commonly comes with giving up smoking.

Though Nicotine replacement patches and other smoking cessation medications help most women smokers, scientists are wondering why the nicotine patch is less effective in women than in men. A future study will look at the association between hormones and women’s success in quitting.

King said, “even though there is not a lot of statistical power behind the findings, still, the results do provide initial evidence of Naltrexone as a smoking cessation aid in women.”


SI
'"/>




Page: 1

Related medicine news :

1. FDA Approves New HIV Drug, Viread
2. FDA Approves New Arthritis Drug, Bextra
3. New Drug, Pleconaril speeds recovery from common cold
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. NGO Files Pre-Grant Opposition Against Anti-HIV Drug, Combivir
6. Life-Saving Cancer Drug, Herceptin Will be Available Free for Breast Cancer Patients in Wales
7. Diabetes Drug, Exenatide, Good For Blood Sugar Levels and Weight Loss
8. FDA Gives Approval for Skin Cancer Drug, Zolinza
9. Was the Warning of a Severe Reaction To a Drug, Overlooked?
10. Teen Marijuana Use Does Not Predict Drug, Alcohol Abuse
11. Skip the Drug, Pick Up Your Shoes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
Breaking Medicine Technology: